TheraIndx Lifesciences
Preferred Research Partner for Preclinical Discovery
Home
About Us
Overview
Team TheraIndx
Vision
Service Models
Data Security
Animal Use
Industries We Serve
Why TheraIndx?
Accreditations & Compliance
Discovery Biology
In vitro
Cell Biology
Cell Based & Cell Free Assays
Immunology
Molecular Biology
In vitro ADMET
Microbiology
Biocompatibility, Biopotency & Bioassays
Biomarkers
In vivo
Pharmacokinetics
Pharmacology
Oncology
PK/PD
Modelling & Simulation
Toxicology
MTD
Acute/Sub-Acute Tox
7/14D DRF
Sub-Chronic Tox
28D Tox
90D Tox
Genotoxicity
Mucous Membrane Irritation
Local Tolerance
Discovery Chemistry
Others
Career
Strategic Partners
Media & Downloads
Blog
Contact
Blog
Home
/
Blog
Pharmacokinetic-Pharmacodynamic (PK/PD) of Anti-infective Agents
Evaluating (PK/PD) Properties of Anti-infective Agents in Preclinical Models of Infection
ORGANOID MODELS FOR CANCER DRUG DISCOVERY
Hollow Fiber models in Cancer Drug Discovery
Patient Derived Xenograft models in Cancer Drug Discovery.
The mouse is the workhorse for cancer studies.
Biomarker can be DNA in a gene, mRNA, an enzyme or a protein.